Who
Mayukh Sukhatme
President & CIO
Company insider
Files Form 4 as: President & CIO, Roivant Sciences.
In numbers
- Trades disclosed
- 115
- Buys
- 0
- Sells
- 16
- Bought
- $0
- Sold
- $204.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Apr 2022
- Last trade
- 16 Oct 2026
- Last filed
- 20 Oct 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Oct 2026filed 20 Oct 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code F | $670K19,976 at $33.53 | filing |
| 30 Sep 2026filed 2 Oct 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code F | $1.7M46,879 at $36.57 | filing |
| 21 Aug 2026filed 21 Aug 2026 | ROIV Roivant Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —144,756 at $0.00 | filing |
| 21 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code M | $557K144,756 at $3.85 | filing |
| 21 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Sold | $5.3M144,756 at $36.48 | filing |
| 21 Aug 2026filed 21 Aug 2026 | ROIV Roivant Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —144,756 at $0.00 | filing |
| 21 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code M | $557K144,756 at $3.85 | filing |
| 21 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Sold | $5.3M144,756 at $36.48 | filing |
| 20 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code M | $67K17,519 at $3.85 | filing |
| 20 Aug 2026filed 21 Aug 2026 | ROIV Roivant Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,519 at $0.00 | filing |
| 20 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Sold | $653K17,519 at $37.30 | filing |
| 20 Aug 2026filed 21 Aug 2026 | ROIV Roivant Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,519 at $0.00 | filing |
| 20 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code M | $67K17,519 at $3.85 | filing |
| 20 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Sold | $653K17,519 at $37.30 | filing |
| 19 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code M | $666K172,899 at $3.85 | filing |
| 19 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Sold | $6.4M172,899 at $37.17 | filing |
| 19 Aug 2026filed 21 Aug 2026 | ROIV Roivant Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —172,899 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | ROIV Roivant Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —172,899 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Code M | $666K172,899 at $3.85 | filing |
| 19 Aug 2026filed 21 Aug 2026 | ROIV Roivant SciencesBiotechnology | SEC FORM 4 Sold | $6.4M172,899 at $37.17 | filing |
News
Roivant Sciences Says Brepocitinib Meets Primary Goal In Uveitis Trials; Shares RiseROIV · rttnews.com · 21 Oct 2026Head to Head Analysis: Roivant Sciences (NASDAQ:ROIV) vs. Pharming Group (NASDAQ:PHAR)ROIV · dailypolitical.com · 14 Oct 2026Analyzing Roivant Sciences (NASDAQ:ROIV) and Krystal Biotech (NASDAQ:KRYS)ROIV · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Mayukh Sukhatme; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.